Bronchodilator response in asthmatic children is significantly reduced when measured immediately after methacholine

Arvid W A Kamps1, Paul L P Brand, Karin Vermeer

  • 1Department of Pediatrics, Division of Pulmonology, Isala Klinieken/Weezenlanden Hospital, PO Box 10500, Groot Wezenland 20, 8000 GM Zwolle, The Netherlands.

Insights

Performing a bronchodilator response (BDR) test immediately after a methacholine challenge in children with asthma is unreliable. The methacholine challenge significantly reduces the measured BDR, making it an unsuitable substitute for a separate test.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Asthma Research

Background:

  • Bronchodilator response (BDR) and methacholine challenge tests are crucial for diagnosing and researching childhood asthma.
  • Current clinical practice often requires separate testing sessions for BDR and methacholine challenges due to practical considerations.

Purpose of the Study:

  • To investigate the feasibility and reliability of measuring BDR immediately following a methacholine challenge test in asthmatic children.
  • To compare BDR measurements obtained with and without a preceding methacholine challenge.

Main Methods:

  • Twenty-four children with asthma and hyperresponsiveness to methacholine underwent BDR testing on two separate days.
  • BDR was assessed by measuring the change in forced expiratory volume in one second (FEV1) after salbutamol inhalation.
  • On one day, BDR was measured immediately after a methacholine challenge; on the other, it was measured independently.

Main Results:

  • A significant reduction in BDR was observed when measured after a methacholine challenge (5.2%) compared to when measured independently (10.8%).
  • Post-bronchodilator FEV1%pred was also lower following the methacholine challenge.
  • Baseline FEV1%pred did not differ significantly between the two testing conditions.

Conclusions:

  • A methacholine challenge significantly attenuates the bronchodilator response in children with asthma.
  • Measuring BDR immediately after a methacholine challenge is not a reliable substitute for a standalone bronchodilator test.
  • Separate testing sessions are necessary for accurate BDR assessment in pediatric asthma evaluations.
Abstract

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...